Reuters logo
3 个月前
BRIEF-Acceleron Pharma qtrly loss per share $0.66
2017年5月8日 / 中午11点37分 / 3 个月前

BRIEF-Acceleron Pharma qtrly loss per share $0.66

May 8 (Reuters) - Acceleron Pharma Inc

* Acceleron pharma reports first quarter 2017 operational and financial results

* Acceleron pharma inc - collaboration revenue for q1 was $3.7 million

* Acceleron pharma inc qtrly loss per share $0.66

* Acceleron pharma inc - plans to initiate luspatercept phase 3 trial in first-line, lower-risk mds in early 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below